Amphastar Pharmaceuticals (AMPH) Change in Acquisitions & Divestments (2016 - 2026)

Amphastar Pharmaceuticals' Change in Acquisitions & Divestments history runs 9 years deep, the most recent figure standing at $15.5 million for Q1 2026.

• In Q1 2026, Change in Acquisitions & Divestments fell 45.2% year-over-year to $15.5 million; the TTM figure through Mar 2026 stood at $77.5 million (down 27.44% YoY), while the FY2025 annual figure was $90.3 million, down 28.35% from the prior year.
• Change in Acquisitions & Divestments for Q1 2026 stood at $15.5 million, down from $16.4 million in the prior quarter.
• The five-year high for Change in Acquisitions & Divestments was $65.8 million in Q2 2024, with the low at -$179000.0 in Q4 2023.
• The 5-year median for Change in Acquisitions & Divestments is $13.6 million (2023), against an average of $17.6 million.
• The sharpest annual moves came in 2023 and 2024: Change in Acquisitions & Divestments plunged 101.43% in 2023, then soared 4281.01% in 2024.
• Amphastar Pharmaceuticals' Change in Acquisitions & Divestments stood at $12.5 million in 2022, then plunged by 101.43% to -$179000.0 in 2023, then jumped by 4281.01% to $7.5 million in 2024, then soared by 119.7% to $16.4 million in 2025, then fell by 5.72% to $15.5 million in 2026.
• Business Quant data shows AMPH's Change in Acquisitions & Divestments at $15.5 million in Q1 2026, $16.4 million in Q4 2025, and $22.5 million in Q3 2025.